A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV
IntroductionCoronaviruses and influenza viruses are significant respiratory pathogens that cause severe disease burdens and economic losses for society. Due to their diversity and evolution, vaccines typically require periodic updating to remain effective. An additional challenge is imposed by the p...
Saved in:
| Main Authors: | Nan Gao, Tianhan Yang, Lanlan Dong, Wanda Tang, Kangli Cao, Longfei Ding, Cuisong Zhu, Shimeng Bai, Ai Xia, Youwei Zhu, Chen Zhao, Haoran Peng, Jianqing Xu, Xiaoyan Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1473428/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge
by: Xiangchuan He, et al.
Published: (2021-01-01) -
Ebola Virus and SARS-CoV-2: Similarities and Differences
by: Robert C. SIZEMORE, et al.
Published: (2020-07-01) -
SARS-CoV-2 Assembly: Gaining Infectivity and Beyond
by: Harshita Katiyar, et al.
Published: (2024-10-01) -
Rapid luminescence-based screening method for SARS- CoV-2 inhibitors discovery
by: Abdeldjalil Madani, et al.
Published: (2025-03-01) -
SARS-CoV-2 Infection in Cancer Patients: Essential Aspects
by: Juan Santiago Serna Trejos, et al.
Published: (2023-01-01)